AKT1 and tongue cancer: The KEGG analysis indicated the potential pathways through which bioactive compounds may exert therapeutic effects on tongue carcinoma are PI3K-Akt signaling pathway, MicroRNAs in cancer, EGFR tyrosine kinase inhibitor resistance and proteoglycans in cancer.